Sung Ahn is working on the development of novel tissue- and organ-targeted contrast agents via machine learning and AI. This goal will be achieved through careful cleaning and managing of our chemical database, and exploration of the deeper statistical significance of each datapoint (various physicochemical properties of each agent). The chemical library consists of information about the targeting and biodistribution organs as well as image analysis data and optical properties of each chemical agent. With this, an algorithm-friendly database will be set up and used such that computers can off insight into drug design and biodistribution prediction.